Cargando…

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease

BACKGROUND: Patients with pulmonary Mycobacterium avium complex (MAC) disease are often co-infected with various pathogenic microorganisms. This study aimed to determine the prevalence of co-infection with non-MAC pathogens and the risk factors associated with co-infection in patients with pulmonary...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fujita, Kohei, Ito, Yutaka, Hirai, Toyohiro, Kubo, Takeshi, Togashi, Kaori, Ichiyama, Satoshi, Mishima, Michiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2014
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212714/ https://www.ncbi.nlm.nih.gov/pubmed/25478192 http://dx.doi.org/10.1136/bmjresp-2014-000050

Ejemplares similares

The influence of environmental exposure on the response to antimicrobial treatment in pulmonary Mycobacterial avium complex disease
por: Ito, Yutaka, et al.
Publicado: (2014)

Preliminary Evaluation of a Sitafloxacin-Containing Regimen for Relapsed or Refractory Pulmonary Mycobacterium avium Complex Disease
por: Fujita, Kohei, et al.
Publicado: (2016)

Multicentre, open label, randomised controlled trial comparing intermittent versus daily treatment for non-cavitary nodular/bronchiectatic Mycobacterium avium complex lung disease with rifampicin, ethambutol and clarithromycin (iREC): study protocol
por: Nakagawa, Taku, et al.
Publicado: (2019)

Association between Mycobacterium avium complex lung disease and serum vitamin D status, antimicrobial peptide levels, and bone mineral density
por: Fujita, Kohei, et al.
Publicado: (2018)

Retrospective study of the predictors of mortality and radiographic deterioration in 782 patients with nodular/bronchiectatic Mycobacterium avium complex lung disease
por: Gochi, Mina, et al.
Publicado: (2015)

Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infection
por: Fairchild, Robert M, et al.
Publicado: (2021)

Characteristics of pulmonary cryptococcosis in patients with rheumatoid arthritis
por: Hosoda, Chiaki, et al.
Publicado: (2021)

Clinical manifestations and outcomes of pulmonary aspergillosis: experience from Pakistan
por: Iqbal, Nousheen, et al.
Publicado: (2016)

Comprehensive evaluation of airway involvement in pulmonary sarcoidosis
por: Tanizawa, Kiminobu, et al.
Publicado: (2017)

Lung microbiota predict invasive pulmonary aspergillosis and its outcome in immunocompromised patients
por: Hérivaux, Anaïs, et al.
Publicado: (2022)

High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors
por: Dhoubhadel, Bhim Gopal, et al.
Publicado: (2022)

Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia
por: Conway Morris, Andrew, et al.
Publicado: (2010)

Current and future management of non-tuberculous mycobacterial pulmonary disease (NTM-PD) in the UK
por: Lipman, Marc, et al.
Publicado: (2020)

Changes in mortality among patients with chronic obstructive pulmonary disease from the 1990s to the 2000s: a pooled analysis of two prospective cohort studies
por: Sato, Susumu, et al.
Publicado: (2023)

Prevalence of swallow, communication, voice and cognitive compromise following hospitalisation for COVID-19: the PHOSP-COVID analysis
por: Dawson, Camilla, et al.
Publicado: (2023)

Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients
por: Ao, Zhi, et al.
Publicado: (2023)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

The effects of sildenafil on ciliary beat frequency in patients with pulmonary non-tuberculous mycobacteria disease: phase I/II trial
por: Fowler, Cedar, et al.
Publicado: (2020)

Face mask sampling reveals antimicrobial resistance genes in exhaled aerosols from patients with chronic obstructive pulmonary disease and healthy volunteers
por: Kennedy, Matthew, et al.
Publicado: (2018)

Ultra-low-dose CT versus chest X-ray for patients suspected of pulmonary disease at the emergency department: a multicentre randomised clinical trial
por: van den Berk, Inge A H, et al.
Publicado: (2023)

Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases
por: Harboe, Zitta Barrella, et al.
Publicado: (2022)

Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study
por: Takeshita, Yuichiro, et al.
Publicado: (2021)

Aetiological agents of adult community-acquired pneumonia in Japan: systematic review and meta-analysis of published data
por: Fujikura, Yuji, et al.
Publicado: (2023)

Serum KL-6 levels predict clinical outcomes and are associated with MUC1 polymorphism in Japanese patients with COVID-19
por: Azekawa, Shuhei, et al.
Publicado: (2023)

Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol
por: Nakagawara, Kensuke, et al.
Publicado: (2021)

Radiological findings in nontuberculous mycobacterial pulmonary diseases: A comparison between the Mycobacterium avium complex and the Mycobacterium abscessus complex
por: Nagano, Hiroaki, et al.
Publicado: (2022)

Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation
por: Wang, H, et al.
Publicado: (2009)

Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
por: Lauder, Sarah N, et al.
Publicado: (2011)

Bronchoalveolar CD4(+) T cell responses to respiratory antigens are impaired in HIV-infected adults
por: Jambo, Kondwani C, et al.
Publicado: (2011)

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
por: Bewick, Thomas, et al.
Publicado: (2011)

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
por: Nguyen-Van-Tam, J S, et al.
Publicado: (2010)

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
por: Ewig, S, et al.
Publicado: (2009)

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
por: Myles, Puja R, et al.
Publicado: (2012)

Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy
por: Spann, Kirsten M, et al.
Publicado: (2014)

Differential response to bacteria, and TOLLIP expression, in the human respiratory tract
por: Moncayo-Nieto, Olga Lucia, et al.
Publicado: (2014)

Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia
por: Dwyer, Richard, et al.
Publicado: (2014)

Metformin reduces airway glucose permeability and hyperglycaemia-induced Staphylococcus aureus load independently of effects on blood glucose
por: Garnett, James P, et al.
Publicado: (2013)

Microbial communities in the respiratory tract of patients with interstitial lung disease
por: Garzoni, Christian, et al.
Publicado: (2013)

British Thoracic Society community acquired pneumonia guideline and the NICE pneumonia guideline: how they fit together
por: Lim, W S, et al.
Publicado: (2015)

Perceptions of medical students towards antibiotic prescribing for upper respiratory tract infections in Saudi Arabia
por: Harakeh, Steve, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_9i01q7cj1rn1qkb8j959bq9g3b